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Intermittent auscultation is the technique used to listen to the fetal
heart rate (FHR) for short periods of time without a display of the
resulting pattern. Whether it is used for intrapartum fetal monitoring
in low-risk women or for all cases in settings where there are no avail-
able alternatives, all healthcare professionals attending labor and
delivery need to be skilled at performing intermittent auscultation,
interpreting its ﬁndings, and taking appropriate action. The main aim
of this chapter is to describe the tools and techniques for intermittent
auscultation in labor.
2. Historical background
Hippocrates is said to have described the technique of listening to
the internal activity of the body by placing the ear on the skin proximal
to the organ under examination. However, the perception of fetal heart
sounds using thismethodwas not reported until the 1600s [1]. Little at-
tention appears to have been given to fetal heart auscultation until
1818,when itwas discussed bybothMayor andde Kergaradec [2] to de-
termine whether the fetus was alive or dead. Interest then accelerated,
and in 1833 Kennedy published a book on the subject of obstetric aus-
cultation [3].☆ Developed by the FIGO Safe Motherhood and Newborn Health Committee;
coordinated by Diogo Ayres-de-Campos.
★ The views expressed in this document reﬂect the opinion of the individuals and not
necessarily the institutions that they represent.
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the adult heart rate is attributed to Laënnec in 1816, who overcame
the embarrassment of placing the ear on a young woman’s chest to
hear her heart beat by rolling sheets of paper into a tube and listening
through this device [2]. This tool was soon replicated in wood, and
gained wide usage for fetal heart auscultation. The most common in-
strument currently used for this purpose is the Pinard stethoscope
(Figs. 1 and 2), but in some countries, notably the USA, the DeLee
stethoscope is used as an alternative (Fig. 3). In both cases, the technol-
ogy has not changed much from the original design, in which a belled
tube creates an ampliﬁcation chamber for sound waves that are trans-
mitted from the fetal heart to the examiner’s ear.
More recently, handheld electronic devices that rely on the Doppler
effect have been used for intermittent auscultation (Fig. 4), a technology
similar to the external FHR monitoring of cardiotocography (CTG).
However, as described in the chapter on CTG [4], these devices do not
transmit the actual sound produced by the fetal heart, but rather a rep-
resentation of this, based on ultrasound-detected movements of fetal
cardiac structures, that are then subject to signalmodiﬁcation and auto-
correlation. Table 1 compares the advantages and disadvantages of the
three instruments currently used for intermittent auscultation.
3. Objectives and indications
As for other approaches to fetal monitoring, the main aim of
intermittent auscultation is the timely identiﬁcation of fetuses with
hypoxia/acidosis to enable appropriate action before the occurrence of
injury. It also allows the conﬁrmation of normal FHR characteristics, so
that unnecessary intervention will be avoided. Systematic reviews of
randomized controlled trials carried out in the 1970s, 1980s, and early
1990s, comparing intermittent auscultation with continuous CTG for
intrapartum monitoring in both low- and high-risk women, have
shown that CTG is associated with a lower risk of neonatal seizures,
but with higher cesarean and instrumental vaginal delivery rates [5].
The limitations of this evidence are analyzed in the chapter on CTG
[4]. There is currently no conclusive evidence for the beneﬁts of contin-
uous CTG versus intermittent auscultation monitoring in labor. There
are also no trials comparing intermittent auscultation with no FHR aus-
cultation during labor.
Based on expert opinion, intermittent auscultation should be recom-
mended in all labors in settings where there is no access to CTG moni-
tors or to the resources necessary for using them. When the resourcesynecology and Obstetrics.
Fig. 1. A Pinard stethoscope.
Fig. 3. A DeLee stethoscope.
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for routine intrapartummonitoring in low-risk cases (Table 2). Howev-
er, approximately half of the panel members believe that continuous
CTG should be the option during the second stage of labor, although
there is no direct scientiﬁc evidence to support this.
4. Advantages of intermittent auscultation
Performing regular intermittent auscultation ensures frequent
contact between healthcare professionals and the laboring woman, of-
fering the opportunity for social and clinical support. It facilitates theFig. 2. Pinard stethoscope in use.assessment of other physical parameters such as maternal skin tone,
temperature, breathing patterns, direct palpation of fetal movements,
and maternal contractions.
Intermittent auscultation permits the fetal heart to be monitored in
various positions and locations and favors the mobility of laboring
women, which has been shown to beneﬁt the progress of labor [7]. An-
other beneﬁt of intermittent auscultation is the easier availability and
sustainability of the technology, which allows it to be undertaken in
even the lowest resource settings.5. Disadvantages of intermittent auscultation
It takes time to develop clinical expertise with intermittent ausculta-
tionwhenperformedwith a fetal stethoscope [8,9]. Initially itmaynot be
easy to recognize the fetal heart sounds, and later there is a slow learning
curve for the identiﬁcation of accelerations and decelerations. Even for
the most experienced healthcare professionals, it is impossible to recog-
nize subtle features of the FHR, such as variability. Using fetal stetho-
scopes, awkward positions sometimes need to be adopted for effective
auscultation and therefore healthcare professionals should ensure good
ergonomic position for themselves and the laboring woman when
using intermittent auscultation. Also with these instruments, there is
no independent record of the FHR and usually no conﬁrmation of the
ﬁndings by other healthcare professionals, or by those in the room.
This may cause uncertainty in case reviews and medico-legal cases.Fig. 4. Handheld Doppler device.
Table 1
Advantages and disadvantages of the instruments used for intermittent auscultation.
Advantages Disadvantages
Pinard stethoscope Inexpensive May be difﬁcult to use in
certain maternal positionsReadily available in most
countries
No consumables needed
DeLee stethoscope Inexpensive May be difﬁcult to use in
certain maternal positionsReadily available in some
countries
No consumables needed
Handheld Doppler More comfortable for the
woman
More costly to purchase and
maintain (requires batteries)
FHR audible to all present
in the room
Can be used in various
maternal positions and
locations (e.g. in water)
Probe is very sensitive to
mechanical damage
May calculate and display
FHR values
May display maternal heart
rate
Table 2
Conditions required for considering and maintaining intermittent auscultation in settings
where cardiotocography is available.
Antepartum factors Intrapartum factors
No serious previous maternal health
conditions
Normal frequency of contractions
No maternal diabetes or pre-eclampsia No labor induction or augmentation
No antenatal vaginal hemorrhage No epidural analgesia
Normal fetal growth, amniotic ﬂuid,
and Doppler
No abnormal vaginal hemorrhage
Normal antenatal cardiotocography
readings
No fresh or thick meconium
No previous uterine scar No maternal temperature N38°C
Normal fetal movements Active ﬁrst stage lasting b12 hours
No rupture of membranes lasting
N24 hours
Second stage lasting b1 hour
Singleton, term, cephalic presentation Clearly audible fetal heart rate
sounds in normal range
Source: Maude et al. [6].
11D. Lewis, S. Downe / International Journal of Gynecology and Obstetrics 131 (2015) 9–12Many of these disadvantages are overcome by the use of a handheld
Doppler. When this device includes a display showing the FHR, even
low variability may be suspected. On the other hand, as occurs with ex-
ternal FHR monitoring in CTG, the device can inadvertently pick up the
maternal heart rate.
Whichever method of intermittent auscultation is used, it may be
difﬁcult to guarantee the continued availability of appropriately trained
staff to attend laboring women in busy labor units.
6. Technique for performing intermittent auscultation
Before intermittent auscultation is initiated, a clear explanation of
the technique and its purpose should be provided to the laboringTable 3
Practice recommendations for intermittent auscultation, uterine contraction, and maternal hea
Features to evaluate
FHR Duration: for at least 60 seconds; for 3 contractions
is not always in the normal range (110−160 bpm).
Timing: during and at least 30 seconds after a contr
Interval: Every 15 minutes in the active phase of th
of labor. Every ﬁve minutes in the second stage of la
Uterine contractions Before and during FHR auscultation, in order to dete
two contractions.
Fetal movements At the same time as evaluation of uterine contractio
Maternal heart rate At the time of FHR auscultation.
Abbreviation: FHR, fetal heart rate; bpm, beats per minute.woman, and her consent obtained. This is followed by an assessment
of the fetal position on abdominal palpation, and placement of the
stethoscope or handheld Doppler over the fetal back as this is where
the heart rate will usually be heard most clearly. Searching for sounds
produced by the fetal heart (usually compared to a “galloping horse”)
rather than those created by fetal vessels (“whoosh” sounds) allows
for a clearer distinction frommaternal heart rate. Simultaneous evalua-
tion of thematernal pulse provides additional reassurance that the FHR
is being monitored. Just before and during intermittent auscultation, a
hand is placed on the uterine fundus to determine the timing of uterine
contractions and to detect fetal movements. If the fetal heart cannot
be identiﬁed unambiguously, ultrasound should be usedwhen available
to determine the FHR and to establish the optimal location for intermit-
tent auscultation.
There are no studies comparing the beneﬁt of different auscultation
intervals. In large randomized trials comparing CTG with intermittent
auscultation, the latter was usually performed every 15 minutes in the
ﬁrst stage and every ﬁve minutes or after every other contraction in
the second stage [5]. While it is recognized that recommendations for
the scheduling of intermittent auscultation are based only on expert
opinion, standardization of procedures is important for planning of
health care and for medical − legal purposes. The recommendations
for performing intermittent auscultation are considered in Table 3.
All features listed in Table 3 should be recorded in dedicated labor
charts to provide an ongoing account of their evolution, and to share
information between caregivers who are or may become involved in
the process.
7. Abnormal ﬁndings and their management
7.1. In settings where continuous CTG is available
Abnormal ﬁndings on intermittent auscultation are listed in Table 4.
If there is doubt as to the characterization of FHR ﬁndings, auscultation
should be prolonged in order to cover at least three contractions.
An FHR value under 110 bpm lasting more than three minutes,
when the rate has previously been normal, is strongly suggestive of a
prolonged deceleration or of fetal bradycardia, and constitutes an
indication for immediate continuous CTG. An FHR value exceeding
160 bpm during three contractions is strongly suggestive of fetal tachy-
cardia, and constitutes an indication for continuous CTG.
Sometimes, decelerations occur because of the maternal supine
position and resulting aortocaval compression. Changing the maternal
positionmay quickly revert the situation. However, if a rapid normaliza-
tion does not ensue, or if repetitive or prolonged decelerations are de-
tected, continuous CTG should be started.
Most accelerations coincide with fetal movements detected by the
mother and/or the healthcare professional, and are a sign of fetal well-
being. However, accelerations occurring just after a contraction do
not usually translate to fetal movements and should motivate ausculta-
tion over at least three contractions in order to rule out the occurrence
of decelerations.rt rate monitoring during labor.
What to register
if the FHR Baseline (as a single counted number in bpm), presence
or absence of accelerations and decelerations.
action.
e ﬁrst stage
bor.
ct at least Frequency in 10 minutes.
ns. Presence or absence.
Single counted number in bpm.
Table 4
Abnormal ﬁndings on intermittent auscultation.
Abnormal ﬁnding
Baseline Below 110 bpm or above 160 bpm
Decelerations Presence of repetitive or prolonged (N3 minutes) decelerations
Contractions More than ﬁve contractions in a 10-minute period
Abbreviation: bpm, beats per minute.
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should lead to evaluation of uterine contractions over 10 minutes.
More than ﬁve contractions detected during this period is considered
tachysystole (see CTG chapter [4]). This constitutes an indication for
continuous CTG, at least until the situation is reversed.
If assessment of the parameters described in Table 3 and the general
behavior of the mother indicate the continuous well-being of both
mother and baby, intermittent auscultation may continue to be the
technique of choice for labor.
7.2. In settings where continuous CTG is not available
If an FHR value under 110 bpm lasting more than ﬁve minutes is
detected—in the absence of maternal hypothermia, known fetal heart
block, or beta-blocker therapy—consideration should be given to imme-
diate delivery by cesarean or instrumental vaginal delivery, according to
obstetric conditions and local resources.
An FHRvalue exceeding160 bpmduring at least three contractions is
suggestive of fetal tachycardia, and should motivate an evaluation of
maternal temperature and signs of intrauterine infection. Beta-agonist
drugs (salbutamol, terbutaline, ritodrine, fenoterol) and parasympathetic
blockers (atropine, scopolamine) are other possible causes. With isolated
fetal tachycardia, increased frequency of intermittent auscultation and
treatment of pyrexia and/or infection need to be considered.
Repetitive decelerations are frequent during the second stage of
labor and may occur as a result of aortocaval, umbilical cord, or fetal
head compression. Changing the maternal position may revert the ﬁrst
two causes. However, if decelerations start more than 20 seconds after
the onset of a contraction and take more than 30 seconds to recover to
baseline values (late decelerations), or when decelerations last
more than three minutes (prolonged decelerations), this is strongly
suggestive of fetal hypoxia/acidosis. If an accompanying tachysystole is
detected, consideration should be given to acute tocolysis with beta-adrenergic agonists (salbutamol, terbutaline, ritodrine), atosiban, or ni-
troglycerine (see physiology chapter [10]), followed by continued aus-
cultation to document the normalization of the pattern. Sudden
maternal hypotension rarely happens during labor in the absence of
conduction analgesia, but should it occur in association with a fetal de-
celeration, increased intravenousﬂuid administration turning themoth-
er to her side and administering intravenous ephedrine will usually
revert the situation. When late and/or prolonged decelerations are doc-
umented during the second stage of labor, the mother should be asked
to stop pushing until this pattern disappears. If there is no rapid reversal
of late and/or prolonged decelerations, consideration should be given to
immediate delivery, by cesarean or instrumental vaginal delivery, ac-
cording to obstetric conditions and local resources.Conﬂict of interest
The authors have no conﬂicts of interest.References
[1] O’Dowd MJ, Philipp EE. The History of Obstetrics and Gynaecology. New York:
Parthenon Publishing Group; 1994.
[2] Freeman RK, Garite TJ, Nageotte MP, Miller LA. History of fetal monitoring. In: Fetal
Heart Rate Monitoring. Philadelphia: Lippincott Williams and Wilkins; 2012.
[3] Kennedy E. Observations on obstetric auscultation. Dublin: Hodges and Smith; 1833.
https://archive.org/details/observationsonob1833kenn. Accessed November 17,
2014.
[4] Ayres-de-Campos D, Spong CY, Chandraharan E. FIGO Intrapartum Fetal Monitoring
Expert Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitor-
ing: Cardiotocography. Int J Gynecol Obstet 2015;131(1):13–24 (in this issue).
[5] Alﬁrevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of
electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane
Database Syst Rev 2013;5:CD006066.
[6] Maude RM, Skinner JP, Foureur MJ. Intelligent Structured Intermittent Auscultation
(ISIA): evaluation of a decision-making framework for fetal heart monitoring of
low-risk women. BMC Pregnancy Childbirth 2014;14:184.
[7] Lawrence A, Lewis L, Hofmeyr GJ, Styles C. Maternal positions and mobility during
ﬁrst stage labour. Cochrane Database Syst Rev 2013;8:CD003934.
[8] Miller FC, Pearse KE, Paul RH. Fetal heart rate pattern recognition by the method of
auscultation. Obstet Gynecol 1984;64(3):332–6.
[9] Schifrin BS, Amsel J, Burdorf G. The accuracy of auscultatory detection of fetal cardiac
decelerations: a computer simulation. Am J Obstet Gynecol 1992;166(2):566–76.
[10] Ayres-de-Campos D, Arulkumaran S. FIGO Intrapartum Fetal Monitoring Expert
Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitoring:
Physiology of fetal oxygenation and the main goals of intrapartum fetal monitoring.
Int J Gynecol Obstet 2015;131(1):5–8 (in this issue).
